Shanghai Junshi Biosciences , Ltd. Profit Margin

As of the most recent data (June 2026), SHJBF shows a profit margin of -14.57%. That compares with -44.99% in the prior-year period — up 67.6% year over year. That is below the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SHJBF's profit margin is now -14.57% (was -44.99%) — a 67.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Shanghai Junshi Biosciences , Ltd. is outperforming or lagging.

The Healthcare sector average profit margin is about 21.34%. Shanghai Junshi Biosciences , Ltd. is at -14.57%, which is lower that average. That is roughly 168.3% below the sector mean. Use the comparison chart on this page to see how SHJBF stacks up against individual peers as well.

That compares with -44.99% in the prior-year period — up 67.6% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Shanghai Junshi Biosciences , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Shanghai Junshi Biosciences , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -14.57%) with ownership activity and broader fundamentals.